Literature DB >> 8221809

Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide.

A Ationu1, D R Singer, A Smith, M Elliott, M Burch, N D Carter.   

Abstract

OBJECTIVE: The aim was to examine the influence of cardiopulmonary bypass on brain natriuretic peptide (BNP) and on hormones of importance in the control of sodium and water balance and blood volume.
METHODS: Nine patients (mean age 4 years, range 2-9) undergoing cardiac surgery were studied. Blood samples were taken before, during, and up to 24 h after bypass. Plasma levels of BNP, atrial natriuretic peptide (ANP), arginine vasopressin (AVP), plasma renin activity, aldosterone, and catecholamines were measured.
RESULTS: Preoperative concentrations of plasma BNP [573(SEM 68) pg.ml-1] and ANP [332(74) pg.ml-1] were greatly increased (p < 0.05) before bypass in all patients when compared to normal levels in children [BNP = 31(4) pg.ml-1; ANP = 27(3) pg.ml-1, n = 28]. With general anaesthetic and sternotomy, there were large reductions (p < 0.05) in both plasma BNP [180(62) pg.ml-1] and plasma ANP [163(59) pg.ml-1]. During bypass, there were no further significant decreases in plasma ANP or BNP concentrations compared with preoperative levels. Postoperatively, plasma BNP gradually increased for 12 h, to 170(28) pg.ml-1, whereas plasma ANP showed a further small decrease, to 107(20) pg.ml-1. However, postoperative plasma levels of both ANP and BNP remained well below preoperative values (p < 0.01). Plasma AVP increased rapidly within 15 min of the onset of bypass, reaching a peak value of 153(5) pg.ml-1 after 45 min. Off bypass, plasma AVP decreased slowly and was still almost 10-fold above preoperative levels 12 h after end of bypass [137(11) pg.ml-1]. Mean central venous pressure decreased during the onset of bypass, from 4.3(1.9) to 0.4(1.1) mm Hg (p < 0.05), and increased again at the end of bypass, to 9.0(3.3) mm Hg (p < 0.05); there was little further change during the postoperative period.
CONCLUSIONS: The major source of plasma BNP in patients with congenital heart disease is the cardiac ventricle. The lower plasma ANP and BNP levels and the narrow band of change in central venous pressure following surgical repair of cardiac abnormalities may be a response to improved cardiac function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221809     DOI: 10.1093/cvr/27.8.1538

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

2.  Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery.

Authors:  T S Mir; C Haun; C Lilje; S Läer; J Weil
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

3.  Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.

Authors:  J G Berry; B Askovich; R E Shaddy; J A Hawkins; C G Cowley
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

4.  Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender.

Authors:  T S Mir; M Flato; J Falkenberg; M Haddad; R Budden; J Weil; S Albers; S Laer
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

5.  A rapid procedure for the quantitation of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects.

Authors:  M R Iascone; S Vittorini; A Collavoli; A Cupelli; G Kraft; A Biagini; A Clerico
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

6.  Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation.

Authors:  Lynn A Sleeper; Page Anderson; Daphne T Hsu; Lynn Mahony; Brian W McCrindle; Stephen J Roth; J Phillip Saul; Richard V Williams; Tal Geva; Steven D Colan; Bernard J Clark
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

7.  Changes in Plasma Atrial and Brain Natriuretic Peptide Levels in Children Undergoing Surgical Isolated Atrial Septal Defect Closure.

Authors:  Yuki Nakamura; Ikuo Hagino; Mitsuru Aoki; Kouji Higashi; Hiromichi Nakajima
Journal:  Pediatr Cardiol       Date:  2015-03-14       Impact factor: 1.655

8.  Brain natriuretic peptide and fluid volume homeostasis--studies during cardiopulmonary bypass surgery.

Authors:  A Ationu; M Burch; M Elliott; N Carter
Journal:  Clin Auton Res       Date:  1993-08       Impact factor: 4.435

9.  Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease.

Authors:  Pierre Tissières; Eduardo da Cruz; Walid Habre; Yacine Aggoun; Noury Mensi; Afksendyios Kalangos; Maurice Beghetti
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

10.  Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour.

Authors:  J Salzmann; D Flitcroft; C Bunce; D Gordon; R Wormald; C Migdal
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.